Trials / Completed
CompletedNCT00956306
A Pharmacokinetic Study of Udenafil in Adult Subjects With or Without Impaired Hepatic Function
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Dong-A Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
This study is designed to assess the effect of hepatic impairment on the pharmacokinetics, safety and tolerability of udenafil in subjects with hepatic impairment compared to healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Udenafil | 100mg Single Oral Dose of Udenafil |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2009-08-11
- Last updated
- 2012-11-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00956306. Inclusion in this directory is not an endorsement.